Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

ACADIA Pharmaceuticals Inc (NASDAQ:ACAD)

34.95
BATS BZX Real-Time Price
As of 12:46pm ET
 +0.59 / +1.72%
Today’s Change
16.64
Today|||52-Week Range
43.89
-1.96%
Year-to-Date
3 Biotech Stocks With Explosive Upside Potential
Aug 23 / MotleyFool.com - Paid Partner Content
Biotech Stock Mailbag: Heron, Acadia, Exact Sciences, Sarepta
Aug 12 / TheStreet.com - Paid Partner Content
Bret Jensen Reporting for Duty
Aug 22 / TheStreet.com - Paid Partner Content
5 Can't-Miss Quotes From ACADIA Pharmaceuticals Inc.'s Q2 Investor Call
Aug 11 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close34.36
Today’s open34.38
Day’s range34.37 - 35.32
Volume46,767
Average volume (3 months)2,455,559
Market cap$4.1B
Dividend yield--
Data as of 12:46pm ET, 08/24/2016

Growth & Valuation

Earnings growth (last year)-71.58%
Earnings growth (this year)-34.28%
Earnings growth (next 5 years)+9.45%
Revenue growth (last year)-49.17%
P/E ratioNM
Price/Sales58,810.80
Price/Book17.53

Competitors

 Today’s
change
Today’s
% change
ICPTIntercept Pharmaceut...+1.07+0.64%
IONSIonis Pharmaceutical...+0.51+1.51%
PTHNPatheon NV-0.21-0.75%
GRFSGrifols SA+0.03+0.18%
Data as of 12:45pm ET, 08/24/2016

Financials

Next reporting dateNovember 7, 2016
EPS forecast (this quarter)-$0.57
Annual revenue (last year)$61.0K
Annual profit (last year)-$164.4M
Net profit margin-269,578.69%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Stephen R. Davis
Vice President-Technology Development &
Operations
James A. Nash
Corporate headquarters
San Diego, California

Forecasts

Partner Offers

Search for Jobs